ABSTRACT
48
Screen participants with abnormal Pap tests are generally referred for gynecological evaluation 62 including colposcopy. Previous studies found that colposcopy was stressful for most women.
63
(1) Not the procedure itself but the prospect of having cancer and risk of dying were the 
96
(7) If these are once again abnormal women are also referred for colposcopy.
97
If histology results of biopsies taken at colposcopy indicate CIN-grade 2 or worse further 98 treatment is performed. A more conservative approach is recommended for women diagnosed
99
with CIN 1 since the majority of these lesions will regress. After two or three consecutive 100 negative smears women with CIN 1 will return to the national screening program.
102
Study design they were asked for written informed consent to participate in the study, which involved
7
In this paper all colposcopy results worse than CIN 1 will be referred to as CIN 2+. 
139

Content of the questionnaires
140
Questionnaires included validated measures on generic HRQoL (11), generic anxiety (12), and 141 screen specific anxiety (13). Generic HRQoL was assessed through the EuroQol classification
142
(EQ-5D) and the 12-item Short-Form Health Survey (SF-12). The EQ-5D consists of 5 items
143
(mobility, self-care, usual activities, pain/ discomfort, and anxiety/ depression). Scores can be we found led us to perform a bootstrap analysis (21) (1,000 replicas) in the program R, (22) 173 while controlling for differences between groups in age.
174
Friedman tests were used to assess changes in HRQoL scores in the study group across 175 multiple measurements. Friedman tests are based on data from those who completed all 176 assessments. For each measure we report how many women completed it at all four time 9 that more anxiety would be reported at baseline if the initial Pap result was more serious.
179
Therefore we assessed HRQoL and anxiety by Pap result (Pap2/3a versus Pap 3b or worse), 180 using t-tests to assess the significance of the differences between groups. We also 181 hypothesized that the more serious the CIN-grade turned out to be, the more anxiety and 182 screen specific anxiety would be reported at follow-up assessments, and therefore we 183 assessed HRQoL and anxiety per CIN group (i.e. no CIN was found versus CIN 1 versus CIN 2+).
184
We used ANOVA to assess the statistical significances of differences in HRQoL and anxiety 
219
The crude PCS-12 scores of the colposcopy group were significantly higher -which indicates 220 better physical functioning -than those of the reference group (54 versus 51, Table 3 ) and than 221 the age adjusted norm score of 51 for the female Dutch population (Statistics Netherlands).
222
The MCS-12 scores of the colposcopy group, however, were lower -which indicates poorer 223 mental functioning -than those of the reference group (47 versus 53, Table 3 ) and than the 224 Dutch norm scores of 52 (Statistics Netherlands). Differences remained significant after 225 controlling for age (Table 3) .
226
Average crude STAI-6 and PCQ scores were higher in the colposcopy group than in the 227 reference population, indicating more generic and screen specific anxiety in women with 228 abnormal smear results. Differences in STAI-scores and in two PCQ subscale scores exceeded 229 the Minimal Important Difference (MID), indicating that the differences between the 230 colposcopy group and the reference population were of clinical relevance (Table 3) .
231
For all scale scores bootstrap analyses resulted in similar conclusions considering statistical 232 significance and clinical relevance as the linear regression analyses.
234
Generic HRQoL and anxiety: results over time
235
Changes over time in the EQ-5D utility score, the EQ-5D 'rating of own health', and the sum 236 score for physical function (PCS-12) were neither statistically significant nor clinically relevant.
237
The scores for mental health score (MSC-12), generic anxiety (STAI-6), and screen-specific 
244
The significance of the difference between the groups decreased from p<0.001 at baseline to 245 0.24 at 6 months follow-up.
246
At 6 months follow-up, HRQoL and generic anxiety scores of the colposcopy group were similar 247 to those of the reference group, while screen-specific anxiety scores remained worse. 
267
The availability of clinical data, which enabled us to discriminate between varying 268 degrees of abnormalities, is one of the strengths of this prospective study. Also, as 269 recommended for quality of life research, we used both generic and screen-specific health 270 measures that had been validated in similar groups as the currently described population. To 
297
In a previous study, women not complying with follow-up protocols reported the 298 highest anxiety scores. (28) Since we only included women who did participate in follow-up 299 protocols, we probably arrived at an underestimation of women's anxiety, even more so 300 because pathologically high levels of anxiety and worry apparently lead to low screening rates.
(4)
302
The negative impact on mental health of abnormal smear results was found to be not 
347
All participating women gave written informed consent.
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108 of the 132 women (82%) completed the fourth assessment at 6 months after baseline.
22 women were excluded from analyses since they had not been referred for gynecological evaluation because of a recent abnormal Pap test result (n=19), or their age was below the threshold of the national cervical cancer screening program (n=3).
132 women were included in the analyses, of whom 117 granted us permission to access their files and/or their treating gynecologist.
154 consecutive patients completed the baseline questionnaire.
Women who were referred to a gynecologist because of abnormal Pap smear results were addressed with a baseline questionnaire.
